to-BBB is a clinical stage biotechnology company developing novel treatments for devastating brain disorders, such as brain cancer and neuroinflammatory diseases. The Company combines existing drugs with to-BBB’s proprietary G-Technology® for enhanced drug delivery across the blood-brain barrier.

Read more

Meet us at

Liposome Research Days - Copenhagen

» 04 August 2014

ECTRIMS - Boston

» 10 September 2014

ESMO - Madrid

» 26 September 2014